Identification of Risk Factors for Gliptin-associated Bullous Pemphigoid among Diabetic Patients

• Main Authors: Dana Shalmon (Author), Efrat Bar-Ilan (Author), Alon Peled (Author), Shamir Geller (Author), Jonathan Bar (Author), Naama Schwartz (Author), Eli Sprecher (Author), Mor Pavlovsky (Author)
• Format: Book
• Published: Medical Journals Sweden, 2024-04-01T00:00:00Z.
• Subjects: article
• Online Access: Connect to this object online.

Drug-associated bullous pemphigoid has been shown to follow long-term gliptin (dipeptidyl-peptidase 4 inhibitors) intake. This study aimed at identifying risk factors for gliptin-associated bullous pemphigoid among patients with type 2 diabetes. A retrospective study was conducted in a tertiary cent...